Isracann enters JV agreement to develop cannabis production in Israel
By Akshay Kedari  Date: 2020-03-27

Isracann enters JV agreement to develop cannabis production in Israel

Isracann Biosciences Inc. has recently entered a joint venture agreement for phased partnership of 2 near-term farm operations at the Sharon Plain region in Israel. This JV agreement will provide significant revenue generating opportunities to the Israel-based cannabis company.

The IMC (Israel Medical Cannabis) compliant farm properties are operating under the preliminary cannabis cultivation and nursery licenses and preparing to start the plantation process within a few weeks. These closely located farms cover a cumulative area of nearly 160,000 sq. ft. greenhouse canopy as well as other infrastructural facilities.

The JV operator/partner is a highly respected, well-known, and active cannabis cultivator. This local partner has a history of operating and maintaining greenhouse operations in the Middle East, with a 2-year experience as productive and stable cannabis farm owners in the Israel market. Their technical proficiency has led to various critical plant genetics being secured for the JV operation.

The JV agreement also complements Isracann’s ongoing Nir Israel medical cannabis project in accordance with agreements held by Cannisra Holdings Ltd., its wholly owned subsidiary.

The JV operation targets a projected dried cannabis yield of 12,600 kg per year, with the plantation expected to start from Q2 of 2020. The initiation of the sales could commence from Q3, which in turn, will support Isracann’s strategy to reduce the time-to-market.

Under the terms of the JV agreement, there is a non-dilutive agreement with a 4 million Israeli Shekel (ILS) or around CAD$1.5 million purchase price to obtain 50% of Sharon Plain operation, subject to approval from IMCA (Israeli Medical Cannabis Agency).

Isracann’s CEO, Darryl Jones has stated that the company conducted a detailed and prolonged face-to-face discussion to ramp up sales in short term, with its new partners in Israel. Concerning the sales perspective, there have been reports and plans to import medical cannabis from Canada to Israel to cater to the growing demand. This has led to the official launch of the commercial activities of the company in Israel and beyond, with all requirements, including partners, permits, facilities and approvals in place.

Source credit:

https://www.globenewswire.com/news-release/2020/03/24/2005178/0/en/Isracann-Enters-JV-for-Near-Term-Cannabis-Farm-Production-Opportunity-in-Israel.html

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

RADCOM introduces automated assurance solution for 5G technology
RADCOM introduces automated assurance solution for 5G technology
By Akshay Kedari

5G technology has been in the headlines for quite a while. Next-generation technology has the potential to transform almost every sector across the world. However, as 5G becomes reality, it has become imperative for service providers to prevent degra...

Sprout to expand wellness solutions lineup by acquiring Vivametrica
Sprout to expand wellness solutions lineup by acquiring Vivametrica
By Akshay Kedari

Sprout, a Canadian company that focuses on delivering innovative solutions for workplace wellbeing, has recently announced the acquisition of predictive health data analytics firm, Vivametrica. According to reliable sources, Sprout plans to enhance t...

Uber halts decision to shift APAC headquarters from Singapore
Uber halts decision to shift APAC headquarters from Singapore
By Akshay Kedari

Uber Technologies Inc., the American ride-hailing giant, has reportedly halted the company’s decision to relocate its Asia Pacific headquarters from Singapore to Hong Kong until December 2022. Sources cite that the company’s decision was...

PCI Pharma extends global clinical supply-chain services in Europe
PCI Pharma extends global clinical supply-chain services in Europe
By Akshay Kedari

U.S. based biopharmaceutical and pharma outsourcing services company, PCI Pharma services has reportedly announced that it reached a noteworthy milestone through the development of COE (Clinical Center of Excellence) in Berlin. According to credible...

Dassault to use Proxem’s AI solution to advance 3DEXPERIENCE platform
Dassault to use Proxem’s AI solution to advance 3DEXPERIENCE platform
By Akshay Kedari

French software company, Dassault Systèmes has recently revealed plans to enhance its 3DEXPERIENCE platform’s collaborative data science abilities, allowing customers to take advantage of their data patrimony by taking part in new v...